{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:27:24Z","timestamp":1790882844873,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.beha.2021.101278","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T01:29:09Z","timestamp":1623893349000},"page":"101278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["GATA2 and marrow failure"],"prefix":"10.1016","volume":"34","author":[{"given":"Francesco","family":"Fabozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Strocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2021.101278_bib1","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.0711824105","article-title":"Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2021.101278_bib2","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2021.101278_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2021.101278_bib5","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib7","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2021.101278_bib8","doi-asserted-by":"crossref","first-page":"101197","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2021.101278_bib9","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41375-018-0134-9","article-title":"GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2 -mutated MDS\/AML","volume":"32","author":"Al Seraihi","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2021.101278_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/10428194.2018.1516039","article-title":"Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation","volume":"60","author":"Kim","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2021.101278_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood.2020005538","article-title":"Somatic genetic rescue in hematopoietic cells in GATA2 deficiency","volume":"136","author":"Catto","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/iub.2204","article-title":"GATA2 mutations in myeloid malignancies: two zinc fingers in many pies","volume":"72","author":"Leubolt","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.beha.2021.101278_bib13","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","article-title":"GATA factor mutations in hematologic disease","volume":"129","author":"Crispino","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.beha.2021.101278_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","article-title":"Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis","volume":"93","author":"Persons","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib16","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1172\/JCI61619","article-title":"Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning","volume":"122","author":"Lim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2021.101278_bib17","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20130751","article-title":"Gata2 is required for HSC generation and survival","volume":"210","author":"de Pater","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2021.101278_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2021.101278_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2021.101278_bib20","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41375-020-0899-5","article-title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","volume":"34","author":"Kozyra","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2021.101278_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2018-03-837336","article-title":"A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing","volume":"132","author":"Wehr","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib22","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1182\/bloodadvances.2020002953","article-title":"Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?","volume":"4","author":"Bresnick","year":"2020","journal-title":"Blood Advances"},{"key":"10.1016\/j.beha.2021.101278_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/cam4.384","article-title":"Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations","volume":"4","author":"Mir","year":"2015","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.beha.2021.101278_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.hoc.2018.04.004","article-title":"Germline GATA2 mutation and bone marrow failure","volume":"32","author":"McReynolds","year":"2018","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.beha.2021.101278_bib26","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2017-09-765214","article-title":"How I treat myelodysplastic syndromes of childhood","volume":"131","author":"Locatelli","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Novakova","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2021.101278_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib30","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/cancers12102962","article-title":"GATA2 related conditions and predisposition to pediatric myelodysplastic syndromes","volume":"12","author":"Bruzzese","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.beha.2021.101278_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/bloodadvances.2020003401","article-title":"A patient with a germline GATA2 mutation and primary myelofibrosis","volume":"5","author":"R\u00fctsche","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2021.101278_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","article-title":"GATA2 deficiency","volume":"15","author":"Hsu","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.beha.2021.101278_bib33","author":"West"},{"key":"10.1016\/j.beha.2021.101278_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.299.299","article-title":"Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency","volume":"126","author":"Pastor Loyola","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib35","author":"Wang"},{"key":"10.1016\/j.beha.2021.101278_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/leu.2016.256","article-title":"Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency","volume":"31","author":"Ding","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2021.101278_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/bloodadvances.2016002311","article-title":"Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency","volume":"1","author":"Fisher","year":"2017","journal-title":"Blood Advances"},{"key":"10.1016\/j.beha.2021.101278_bib38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.5MA0815-388R","article-title":"Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations","volume":"99","author":"Maciejewski-Duval","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.beha.2021.101278_bib40","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jhep.2016.01.017","article-title":"Single-gene association between GATA-2 and autoimmune hepatitis: a novel genetic insight highlighting immunologic pathways to disease","volume":"64","author":"Webb","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.beha.2021.101278_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/bjd.15548","article-title":"Skin manifestations among GATA2-deficient patients","volume":"178","author":"Polat","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.beha.2021.101278_bib42","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbmt.2020.02.015","article-title":"Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2 mutations","volume":"26","author":"Hofmann","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2021.101278_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00178-2017","article-title":"Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis","volume":"49","author":"Sanges","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.beha.2021.101278_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00407-2017","article-title":"Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis","volume":"49","author":"Jouneau","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.beha.2021.101278_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjd.14062","article-title":"Merkel cell carcinoma in a patient with GATA2 deficiency: a novel association with primary immunodeficiency","volume":"174","author":"Crall","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.beha.2021.101278_bib47","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/dvdy.22373","article-title":"Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space","volume":"239","author":"Haugas","year":"2010","journal-title":"Dev Dynam"},{"key":"10.1016\/j.beha.2021.101278_bib48","doi-asserted-by":"crossref","first-page":"e13433","DOI":"10.1111\/aji.13433","article-title":"Uterinenatural killer cells and recurrent spontaneous abortion","author":"Fu","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.beha.2021.101278_bib49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.16247","article-title":"GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner","volume":"188","author":"Bogaert","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2021.101278_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01423","article-title":"Bacille calmette\u2013guerin complications in newly described primary immunodeficiency diseases: 2010\u20132017","volume":"9","author":"Nunes-Santos","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.beha.2021.101278_bib51","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lrr.2015.10.001","article-title":"Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation","volume":"4","author":"L\u00fcbking","year":"2015","journal-title":"Leukemia Research Reports"},{"key":"10.1016\/j.beha.2021.101278_bib53","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/TP.0000000000000520","article-title":"Allogeneic hematopoietic cell transplantation for GATA2 deficiency in a patient with disseminated human papillomavirus disease","volume":"98","author":"Maeurer","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2021.101278_bib54","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2017-10-811489","article-title":"In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction","volume":"131","author":"Tholouli","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood-2018-02-826461","article-title":"HSCT for GATA2 deficiency across the pond","volume":"131","author":"Hickstein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2021.101278_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2021.101278_bib57","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2021.101278_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2021.101278_bib59","article-title":"From basic biology to patient mutational spectra of GATA2 haploinsufficiencies: what are the mechanisms, hurdles, and prospects of genome editing for treatment","volume":"2","author":"Koyunlar","year":"2020","journal-title":"Front Genome"},{"key":"10.1016\/j.beha.2021.101278_bib60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2020007001","article-title":"Natural gene therapy in hematopoietic disorders: GATA too","volume":"136","author":"Jongmans","year":"2020","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692621000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692621000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:07:38Z","timestamp":1761498458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692621000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1521692621000438"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2021.101278","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GATA2 and marrow failure","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2021.101278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101278"}}